Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Om P Ganda

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of the American Heart Association|August 29, 2025
Adherence to Lipid-Lowering Therapies and Cardiovascular Outcomes in Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-AnalysisLaney K Jones, Cara East, Om P Ganda, et al.
Journal of the American College of Cardiology|June 25, 2018
Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia ManagementOm P Ganda, Deepak L Bhatt, R Preston Mason, et al.
Archives of Internal Medicine|October 12, 2011
The effect of a structured behavioral intervention on poorly controlled diabetes: a randomized controlled trialKatie Weinger, Elizabeth A Beverly, Yishan Lee, et al.
Diabetes Care|January 15, 2013
Do older adults aged 60-75 years benefit from diabetes behavioral interventions?Elizabeth A Beverly, Shane Fitzgerald, Lilya Sitnikov, et al.
The Diabetes Educator|May 4, 2013
Impact of reinforcement of diabetes self-care on poorly controlled diabetes: a randomized controlled trialElizabeth A Beverly, Shane M Fitzgerald, Kelly M Brooks, et al.
Diabetes, Obesity & Metabolism|May 27, 2018
Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trialsOm P Ganda, Jorge Plutzky, Santosh K Sanganalmath, et al.
Journal of Clinical Lipidology|March 27, 2025
Comparison of product label vs real-world safety data from branded icosapent ethyl users: A select analysis utilizing MarketScan dataJohn R Nelson, Richard A Hansen, Handrean Soran, et al.
American Journal of Preventive Cardiology|July 30, 2021
Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocolBruce A Warden, Joshua R Miles, Carlota Oleaga, et al.
Diabetes Care|May 24, 2012
Look who's (not) talking: diabetic patients' willingness to discuss self-care with physiciansElizabeth A Beverly, Om P Ganda, Marilyn D Ritholz, et al.
Journal of Clinical Lipidology|November 24, 2011
Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literatureBijan Roshan, Om P Ganda, Ranil Desilva, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of the American Heart Association|August 29, 2025
Adherence to Lipid-Lowering Therapies and Cardiovascular Outcomes in Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-AnalysisLaney K Jones, Cara East, Om P Ganda, et al.
Journal of the American College of Cardiology|June 25, 2018
Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia ManagementOm P Ganda, Deepak L Bhatt, R Preston Mason, et al.
Archives of Internal Medicine|October 12, 2011
The effect of a structured behavioral intervention on poorly controlled diabetes: a randomized controlled trialKatie Weinger, Elizabeth A Beverly, Yishan Lee, et al.
Diabetes Care|January 15, 2013
Do older adults aged 60-75 years benefit from diabetes behavioral interventions?Elizabeth A Beverly, Shane Fitzgerald, Lilya Sitnikov, et al.
The Diabetes Educator|May 4, 2013
Impact of reinforcement of diabetes self-care on poorly controlled diabetes: a randomized controlled trialElizabeth A Beverly, Shane M Fitzgerald, Kelly M Brooks, et al.
Diabetes, Obesity & Metabolism|May 27, 2018
Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trialsOm P Ganda, Jorge Plutzky, Santosh K Sanganalmath, et al.
Journal of Clinical Lipidology|March 27, 2025
Comparison of product label vs real-world safety data from branded icosapent ethyl users: A select analysis utilizing MarketScan dataJohn R Nelson, Richard A Hansen, Handrean Soran, et al.
American Journal of Preventive Cardiology|July 30, 2021
Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocolBruce A Warden, Joshua R Miles, Carlota Oleaga, et al.
Diabetes Care|May 24, 2012
Look who's (not) talking: diabetic patients' willingness to discuss self-care with physiciansElizabeth A Beverly, Om P Ganda, Marilyn D Ritholz, et al.
Journal of Clinical Lipidology|November 24, 2011
Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literatureBijan Roshan, Om P Ganda, Ranil Desilva, et al.
Pageof 3